About the Basal Cell Carcinoma Session
Basal cell carcinoma (BCC) is the most common form of skin cancer, often caused by prolonged exposure to ultraviolet (UV) radiation from the sun. In Cancer Research, understanding the genetic mutations driving BCC has led to targeted therapies like hedgehog pathway inhibitors. These drugs disrupt the signaling pathway implicated in BCC development, offering promising outcomes for patients with advanced or metastatic BCC. Moreover, research into immunotherapies for BCC is gaining traction, harnessing the body's immune system to recognize and destroy cancer cells. Despite advancements, prevention remains crucial, emphasizing sun protection measures and regular skin screenings. Continued research endeavors aim to enhance treatment efficacy, minimize side effects, and ultimately improve the prognosis for individuals affected by basal cell carcinoma.
Topics Covered in Basal Cell Carcinoma
Ultraviolet Radiation
Histologic Subtypes
Dermoscopic Diagnosis
Micrographic Surgery
Hedgehog Pathway Inhibitors
Locally Advanced Disease
Related Scientific Sessions at CIOC 2027
Why Attend the Basal Cell Carcinoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Basal Cell Carcinoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Basal Cell Carcinoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Basal Cell Carcinoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Basal Cell Carcinoma Conference 2027 — FAQs
What is the Basal Cell Carcinoma track at CIOC 2027?
The Basal Cell Carcinoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Basal Cell Carcinoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Basal Cell Carcinoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Basal Cell Carcinoma are all welcome — whether presenting or attending.
Can I present my research in the Basal Cell Carcinoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Basal Cell Carcinoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Basal Cell Carcinoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.